The removal by papain of a histocompatibility antigen, HL-A 2, from the surface of intact peripheral blood lymphocytes has been examined. Up to 80% of the antigenic determinant can be removed within 90 minutes. If the cells are reincubated in nutritive medium, re-expression of HL-A 2 is complete within 6 hours. Reexpression is reversibly inhibited by puromycin (50 ug/ml), but actinomycin D (6 ug/ml) only partially inhibited reexpression after 2 hours of prior incubation with the drug.
Transplantation antigens determined by the H-2 genetic locus in mice and the HL-A locus in man are known to be densely expressed on lymphocytes (1, 2) . They occur principally on the surface membrane (3, 4) and can be removed by various procedures, including the use of proteolytic enzymes (5) , autolytic procedures (6), detergents (7) , ultrasonic radiation (8) , and high salt concentrations (9) . Among enzymic methods, papain treatment of membrane preparations, introduced by Nathenson and Shimada (10), reproducibly yields a soluble product of molecular weight 30,000-60,000 about which considerable structural information is now being accumulated. The immunochemical determinants of these H-2 or HL-A substances reside in glycoproteins, separable in some cases by size or anionic charge into molecules specific in their inhibition of defined H-2 or HL-A isoantisera.
Enzymic removal of histocompatibility specificities from the intact cell in isotonic medium has the potential advantage of leaving the synthetic capacity of the cell unimpaired. The removal of the HL-A 2 determinants from the surface of normal human peripheral lymphocytes by papain in a nutritive medium, and the subsequent reappearance of specificity after enzyme removal followed by incubation in a nutritive medium, have therefore been examined. Analogous studies on a mouse tumor (Meth A) have recently been reported (11) . The present work extends these studies to normal human peripheral lymphocytes, and suggests that protein synthesis, but not RNA synthesis, is essential for the renewed surface expression of HL-A 2 antigen.
MATERIALS AND METHODS
Lymphocytes. Lymphocytes were separated from freshly drawn, defibrinated blood by discontinuous gradient centrifugation on a solution of Ficoll (Pharmacia) and Hypaque (Winthrop Laboratories), as described by Boyum (12 digestion. Cells at a concentration of 5 X 107 per ml were incubated with a 0.37% solution of cysteine-activated papain for 90 min. Cells were removed by centrifugation, an aliquot of the supernatant was removed, and the papain was inactivated by the addition of an equal volume of 10 mM iodoacetate in phosphate-buffered saline. The ability of the solubilized material to inhibit anti-HIA 2 antiserum and (as a specificity control) anti-HL-A 7 antiserum was examined by a routine inhibition assay (14) . The results showed that about 35% of the original HLA 2 inhibitory activity of the cells was present in solubilized form. A-A, 6 hr of reincubation in the presence of puromycin; O-O, 6 hr of reincubation in the presence of puromycin, then a further 6-hr incubation after removal of puromycin. Fig. 3 (Fig. 2) .
Effects of puromycin and actinomycin D on re-expression of HL-A 2
Papain-treated cells were reincubated in the same medium as above containing puromycin (50 ;g/ml) or actinomycin D (6 /Ag/ml). After 6 hr of incubation, their adsorptive capacity for anti-HILA 2 antiserum was measured. Puromycin completely inhibited resynthesis of HL-A 2 (Fig. 3) . Cells that had been incubated with puromycin for 6 hr were washed twice to remove the antibiotic, and were then resuspended at 106 cells per ml. After a further 6 hr of incubation at 37°C, resynthesis was complete. Thus, the effect of puromycin could be reversed by removal of the antibiotic.
Cells were incubated in the presence of actinomycin for 30 min, and then for an additional 90 min during the papain treatment. During the subsequent incubation in nutritive medium, actinomycin D was also present; nevertheless, about 70% of HLA 2 was re-expressed in 6 hr (Fig. 4) . In a control experiment, the incorporation of ['H]uridine into acid-insoluble material (RNA) (15) was inhibited at least resuspended at a concentration of 106 cells per ml. Adsorption of aliquots of antiserum was performed as described in Fig. 1 at hourly intervals. Each point is the mean of three values. These results were duplicated with two cell types (MeTu and JaSt). Proc. Nat. Acad. Sci. USA 69 (1972) 98% by actinomycin D. These data suggest that normal human peripheral lymphocytes contain a messenger RNA for HL-A 2 synthesis that is stable for at least 2 hr. Additional experiments in cultured cells (RPMI 1788) indicate that actinomycin D does inhibit re-expression of HL-A 7 completely after 4 hr of incubation with the drug, but only slightly (30%) after 2.5 hr of incubation.
DISCUSSION
Peripheral human lymphocytes appear to retain their membrane integrity when incubated with activated papain in an isotonic medium, since papain-treated 5"Cr-labeled cells release radioactivity into the medium at the same rate as untreated cells. However, the removal of HL-A determinants could not be followed with a complement-mediated cytotoxic assay. The normal rabbit serum used as a source of complement in such a test was found to be cytolytic for "stripped" cells in the absence of antiserum (certainly it is not toxic for normal human lymphocytes). This finding may be related to similar results obtained with lymphoid cells that have been treated with neuraminidase (16) . The enhanced sensitivity to serum has been attributed to the uncovering of determinants on the cell surface to which there are antibodies (possibly of a cross-reacting nature) in several mammalian sera (17) . The present results are compatible with such a suggestion.
The indirect adsorption assay that we used overcomes the problems associated with complement cytotoxicity; our results indicate that up to 80% of HL-A 2 determinants are removed during a 90-min incubation with papain. The remaining antigen may be in a privileged site, chemically or stereochemically resistant to enzymic digestion, or it may represent a cross-reacting material that is not removed by papain. Resynthesis of a small amount of HL-A 2 during the incubation period for adsorption of antiserum in the absence of papain could also account for the finding.
Reappearance of HL-A 2 determinants proceeds until the original cellular complement of antigen is restored. No significant increase over the original content of HL-A 2 was observed with the cell type studied. Inhibition of resynthesis by puromycin, which blocks protein synthesis by displacing growing peptide chains from ribosomes (18) , suggests that HL-A 2 is resynthesized de novo and that a large pool of preformed determinants is not present in the cells. This conclusion is in line with earlier work (3) indicating that completely disrupted cells had only marginally more absorptive capacity than was present on the surface of a similar number of intact cells.
Actinomycin D appears to be only partially inhibitory after a 2-hr incubation. Actinomycin D blocks DNA-dependent RNA synthesis (15) . The failure of actinomycin to fully inhibit resynthesis under these conditions suggests that a mRNA coding for the antigen exists within the cell, and that papain digestion is not necessary to promote transcription. Thus, antigen expression may be controlled at the translational level, or the presence of the messenger may indicate a continuous turnover of the surface antigen. A similar finding has been reported (19) for the regeneration of sialic acid on the surface of Chinese hamster cells in culture.
The kinetics of re-expression may be similar to those presented briefly for Meth A mouse tumor cells in culture (11) . It will be of interest to examine whether products of both HL-A subloci are re-expressed at similar rates, if in cis or trans genetic configuration, as well as to examine the regeneration rate for a single specificity in homozygous or heterozygous quantity. It is known that the expression of HL-A 1 at the surface of lymphocytes in a heterozygous individual is half that of a related homozygote (20) .
